Status:

COMPLETED

Efficacy and Safety of SR46349B in Patients With Sleep Disorders in Fibromyalgia

Lead Sponsor:

Sanofi

Conditions:

Fibromyalgia

Sleep

Eligibility:

All Genders

18-64 years

Phase:

PHASE2

Brief Summary

Fibromyalgics frequently report sleep disturbances, in particular poor and unrefreshing sleep. Additionally, studies have reported that sleep problems, pain and mood disturbances are associated in pat...

Detailed Description

The purpose of this research study is to investigate the effectiveness and safety of 2 doses of the investigational product in subjects with sleep disorders with fibromyalgia as compared to placebo (a...

Eligibility Criteria

Inclusion

  • Each patient must fulfill the diagnosis criteria of fibromyalgia according to the American College of Rheumatology
  • Based on patient's information:
  • The patient must complain of unrefreshing sleep for at least 3 nights per week over the past month.
  • The patient spends at least 6.5 hours and not more than 9 hours, in bed, each night over the past 2 weeks.
  • Female patients of childbearing potential must have a confirmed negative pregnancy test at the end of the screening period and use an acceptable method of birth control throughout the study
  • Written, signed and dated informed consent must be obtained from each patient
  • Willing to abstain from taking any medication or treatment prohibited as per the protocol

Exclusion

  • Females who are lactating or pregnant
  • Night shift workers, and individuals who nap 3 or more times per week over the preceding month (nap: intentionally sleeping for more than 20 minutes during the day).
  • Consumption of beverage with caffeine (i.e. tea, coffee, or cola) comprising more than 2 cups or glasses per day
  • Past or Current medical history of any significant, severe, or unstable acute or chronically progressive medical or surgical disorder which may affect patient safety

Key Trial Info

Start Date :

April 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2005

Estimated Enrollment :

205 Patients enrolled

Trial Details

Trial ID

NCT00313885

Start Date

April 1 2004

End Date

June 1 2005

Last Update

November 30 2010

Active Locations (12)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (12 locations)

1

Radiant Research

Phoenix, Arizona, United States, 85013

2

San Diego Arthritis Medical Clinic

San Diego, California, United States, 92108

3

Jacksonville Center for Clinical Research

Jacksonville, Florida, United States, 32216

4

Miami Research Assoc., Inc.

Miami, Florida, United States, 33173

Efficacy and Safety of SR46349B in Patients With Sleep Disorders in Fibromyalgia | DecenTrialz